Lava Therapeutics
Investment
area
Novo Ventures
Novo Ventures
Region
Europe
Europe
Date of
investment
August 2020
August 2020
Developing next generation bispecific gamma-delta T cell engaging (bsTCE) antibodies to fight cancer.
Lava Therapeutics
Investment
area
Novo Ventures
Novo Ventures
Region
Europe
Europe
Date of
investment
August 2020
August 2020
Developing next generation bispecific gamma-delta T cell engaging (bsTCE) antibodies to fight cancer.
Lava Therapeutics
Investment
area
Novo Ventures
Novo Ventures
Region
Europe
Europe
Date of
investment
August 2020
August 2020
Website
Visit their website
Visit their website
Developing next generation bispecific gamma-delta T cell engaging (bsTCE) antibodies to fight cancer.